-
Mashup Score: 6
The number of mutations in the DNA of cancerous tumors may not be an indicator of how well patients will respond to immune checkpoint inhibitors (ICIs), a commonly prescribed type of immunotherapy, a …
Source: medicalxpress.comCategories: General Medicine News, General HCPsTweet
#Tumor #mutations may not predict response to immunotherapy, study finds @UTSWNews @naturecancer https://t.co/SpPY4GWAE4